Dr Reddy's gets FDA warning letter for three drug plants
Drug firm Dr Reddy's Laboratories said it has received a warning letter from US health regulator over inadequate quality control procedures at its three drug manufacturing units in India. Check out the video for more information.
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
